What is Remdesivir?

Remdesivir (GS-5734) is an investigational antiviral drug developed by Gilead Sciences. It is a novel, oral, single-agent therapy that is being developed for the treatment of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) infections. 

How does Remdesivir work?

Remdesivir is a nucleoside analogue that inhibits the replication of SARS-CoV and MERS-CoV by blocking the viral RNA-dependent RNA polymerase. 

What is the Remdesivir cocktail?

The Remdesivir cocktail is a combination of Remdesivir, …